医薬品マーケティング市場：カテゴリー別、流通別、ビジネスモデル別-2025-2030年世界予測

医薬品マーケティング市場の2023年の市場規模は411億9,000万米ドルで、2024年には460億3,000万米ドルに達すると予測され、CAGR 12.26%で成長し、2030年には925億5,000万米ドルに達すると予測されています。

医薬品マーケティングの対象範囲には、ブランド認知度の向上と販売促進を中心に、ヘルスケア専門家や消費者に対する医薬品の販売促進活動が含まれます。これには、デジタルと従来のマーケティング戦略の両方を統合したハイブリッドなアプローチが含まれます。医薬品マーケティングの必要性は、複雑な規制環境に対応し、医薬品情報を正確に伝え、倫理基準を維持する必要性によって強調されます。医薬品マーケティングは、医薬品の上市、ライフサイクル管理、患者エンゲージメント、アドヒアランスプログラムなどに応用できます。最終用途には、病院、診療所、小売薬局、オンラインプラットフォームなどが含まれます。市場促進要因としては、製剤技術の進歩、慢性疾患の増加、高齢化の進展などが挙げられます。デジタルヘルスと遠隔医療の台頭は、消費者が便利なヘルスケアソリューションを求めるようになり、有利な機会をもたらしています。製薬会社は新興市場を取り込むため、個別化医療やデジタルツールに投資することが推奨されています。しかし、厳しい規制の枠組み、高い研究開発費、市場競争は大きな課題となっています。また、消費者への直接広告をめぐる倫理的な監視も障害となっており、慎重な判断が求められています。このような課題にもかかわらず、イノベーションの機が熟している分野には、医薬品開発やターゲットを絞ったマーケティング・キャンペーンにおける予測分析のためのAIやビッグデータの活用が含まれます。製薬と患者中心のサービスの橋渡しをする統合ヘルスケアソリューションは、ビジネスの成長機会を提供する可能性があります。さらに、バイオシミラーや生物製剤市場の開拓も可能性があります。市場の動向を洞察すると、倫理的なマーケティング慣行と持続可能性がますます重視され、世界化の傾向が見られます。企業は競争力を維持するために、強固なパイプラインの構築と協力関係の促進に注力すべきです。急速に進化する市場情勢には、利害関係者との透明性と信頼関係を維持しながら、消費者の要求の変化や規制状況の変化に適応できる機敏なマーケティング戦略が必要です。

市場力学：急速に進化する医薬品マーケティング市場の主要市場インサイトを公開

医薬品マーケティング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬研究の増加と製品アクセス向上の必要性
  • 医薬品のポジショニングと価格設定の必要性
  • 規制当局による医薬品承認の増加
• 市場抑制要因
  • 医薬品マーケティングにかかる膨大なコスト
• 市場機会
  • 医薬品マーケティングへのデジタルツールの統合
  • 価値に基づく個別化アプローチへのシフト
• 市場の課題
  • 誤解を招くマーケティングと厳しい規制環境に伴う問題

ポーターのファイブフォース：医薬品マーケティング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品マーケティング市場における外部からの影響の把握

外部マクロ環境要因は、医薬品マーケティング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品マーケティング市場における競合情勢の把握

医薬品マーケティング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医薬品マーケティング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品マーケティング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医薬品マーケティング市場における成功への道筋を描く

医薬品マーケティング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品調査の増加と製品アクセスの拡大の必要性
    • 医薬品の位置付けと価格設定を活用する必要性
    • 規制当局による医薬品承認の増加
  • 抑制要因
    • 医薬品マーケティングの大幅なコスト
  • 機会
    • 医薬品マーケティングにおけるデジタルツールの統合
    • 価値に基づいたパーソナライズされたアプローチへの移行
  • 課題
    • 誤解を招くマーケティングと厳しい規制環境に関連する問題
• 市場セグメンテーション分析
  • カテゴリ：ウェブサイトのページとキャンペーンは、医薬品の商品化における医薬品マーケティング戦略において重要です
  • 流通：PCD製薬フランチャイズは、製薬会社全体の急速な市場拡大を可能にします
  • ビジネスモデル：B2Bマーケティングは、規制当局が定める高い基準を満たすために、より技術的なアプローチを重視し、価値あるヘルスケアソリューションを提供します。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 医薬品マーケティング市場：カテゴリ別

• カンファレンスマーケティング
• PPC広告
• 印刷広告
• ソーシャルメディアキャンペーン
• テレビコマーシャル
• ウェブサイトページとキャンペーン

第7章 医薬品マーケティング市場配布元

• ジェネリック医薬品のマーケティング
• 機関投資家向け供給
• オンライン薬局
• OTC（店頭販売）マーケティング
• PCD製薬フランチャイズ

第8章 医薬品マーケティング市場：ビジネスモデル別

• 企業向け
• B2C

第9章 南北アメリカの医薬品マーケティング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の医薬品マーケティング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの医薬品マーケティング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • JBケミカルズ、ジェネリック医薬品の販売で米国FDAの承認を取得
  • 製薬業界のための2つの新たなパートナーシップ
  • サンファーマ、コンサートファーマシューティカルズの買収を完了
• 戦略分析と提言

企業一覧

• Amgen Inc.
• AstraZeneca PLC
• Biogen Inc.
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Company
• Eli Lilly & Company
• F. Hoffmann-La Roche AG
• GlaxoSmithKline PLC
• Merck & Co. Inc.
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL MARKETING MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL MARKETING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PHARMACEUTICAL MARKETING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PHARMACEUTICAL MARKETING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL MARKETING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL MARKETING MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY CONFERENCE MARKETING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY PPC ADVERTISING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY PRINT ADVERTISING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY SOCIAL MEDIA CAMPAIGNS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY TV COMMERCIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY WEBSITE PAGES & CAMPAIGNS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY GENERIC DRUG MARKETING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY INSTITUTIONAL SUPPLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY OTC (OVER THE COUNTER) MARKETING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY PCD PHARMA FRANCHISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY B2B, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL MARKETING MARKET SIZE, BY B2C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 33. CANADA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PHARMACEUTICAL MARKETING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 50. CHINA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 51. CHINA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 53. INDIA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 54. INDIA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 105. ITALY PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 106. ITALY PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 117. POLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 118. POLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 120. QATAR PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 121. QATAR PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM PHARMACEUTICAL MARKETING MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM PHARMACEUTICAL MARKETING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM PHARMACEUTICAL MARKETING MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
• TABLE 150. PHARMACEUTICAL MARKETING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. PHARMACEUTICAL MARKETING MARKET, FPNV POSITIONING MATRIX, 2023

The Pharmaceutical Marketing Market was valued at USD 41.19 billion in 2023, expected to reach USD 46.03 billion in 2024, and is projected to grow at a CAGR of 12.26%, to USD 92.55 billion by 2030.

The scope of pharmaceutical marketing encompasses the activities involved in promoting pharmaceutical products to healthcare professionals and consumers, with a focus on building brand awareness and driving sales. This involves a hybrid approach integrating both digital and traditional marketing strategies. The necessity for pharmaceutical marketing is underscored by the need to navigate complex regulatory environments, ensuring accurate dissemination of drug information and maintaining ethical standards. It finds applications across drug launches, lifecycle management, patient engagement, and adherence programs. The end-use scope includes hospitals, clinics, retail pharmacies, and online platforms. Market insights reveal that key growth drivers include technological advancements in drug formulation, increased prevalence of chronic diseases, and a growing aging population. The rise of digital health and telemedicine presents lucrative opportunities as consumers seek convenient healthcare solutions. Pharmaceutical companies are recommended to invest in personalized medicine and digital tools to capture emerging markets. However, stringent regulatory frameworks, high R&D costs, and market competition pose significant challenges. Another impediment is the ethical scrutiny faced over direct-to-consumer advertising, necessitating careful navigation. Despite these challenges, areas ripe for innovation include leveraging AI and big data for predictive analytics in drug development and targeted marketing campaigns. Integrated healthcare solutions bridging pharma with patient-centric services could provide business growth opportunities. Moreover, exploring biosimilars and biologics markets promises potential. Insight into the market's nature indicates a trend toward globalization, accompanied by an increasing emphasis on ethical marketing practices and sustainability. Companies should focus on building robust pipelines and fostering collaborations to remain competitive. The rapidly evolving landscape requires agile marketing strategies that can adapt to shifting consumer demands and regulatory changes while maintaining transparency and trust with stakeholders.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Marketing Market

The Pharmaceutical Marketing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in pharmaceutical research and the need to increase product access
  • Need for leveraging pharmaceutical product positioning and pricing
  • Rise in drug approvals by regulatory bodies
• Market Restraints
  • Substantial cost of pharmaceutical marketing
• Market Opportunities
  • Integration of digital tools in pharmaceutical marketing
  • Shift towards a value-based and personalized approach
• Market Challenges
  • Problems associated with misleading marketing and strict regulatory environment

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Marketing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Marketing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Marketing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Marketing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Marketing Market

A detailed market share analysis in the Pharmaceutical Marketing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Marketing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Marketing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Marketing Market

A strategic analysis of the Pharmaceutical Marketing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Marketing Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Eli Lilly & Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Marketing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Category, market is studied across Conference Marketing, PPC Advertising, Print Advertising, Social Media Campaigns, TV Commercials, and Website Pages & Campaigns.
• Based on Distribution, market is studied across Generic Drug Marketing, Institutional Supply, Online Pharmacies, OTC (Over The Counter) Marketing, and PCD Pharma Franchise.
• Based on Business Model, market is studied across B2B and B2C.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in pharmaceutical research and the need to increase product access
    • 5.1.1.2. Need for leveraging pharmaceutical product positioning and pricing
    • 5.1.1.3. Rise in drug approvals by regulatory bodies
  • 5.1.2. Restraints
    • 5.1.2.1. Substantial cost of pharmaceutical marketing
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of digital tools in pharmaceutical marketing
    • 5.1.3.2. Shift towards a value-based and personalized approach
  • 5.1.4. Challenges
    • 5.1.4.1. Problems associated with misleading marketing and strict regulatory environment
• 5.2. Market Segmentation Analysis
  • 5.2.1. Category: Website pages & campaigns are crucial in pharmaceutical marketing strategies for commercializing pharma product
  • 5.2.2. Distribution: PCD pharma franchises enable rapid market expansion for over-all pharmaceutical companies
  • 5.2.3. Business Model: B2B marketing emphasize more technical approach to meet the high standards set by regulatory agencies while providing valuable healthcare solutions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Marketing Market, by Category

• 6.1. Introduction
• 6.2. Conference Marketing
• 6.3. PPC Advertising
• 6.4. Print Advertising
• 6.5. Social Media Campaigns
• 6.6. TV Commercials
• 6.7. Website Pages & Campaigns

7. Pharmaceutical Marketing Market, by Distribution

• 7.1. Introduction
• 7.2. Generic Drug Marketing
• 7.3. Institutional Supply
• 7.4. Online Pharmacies
• 7.5. OTC (Over The Counter) Marketing
• 7.6. PCD Pharma Franchise

8. Pharmaceutical Marketing Market, by Business Model

• 8.1. Introduction
• 8.2. B2B
• 8.3. B2C

9. Americas Pharmaceutical Marketing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pharmaceutical Marketing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Marketing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. JB Chemicals Gets USFDA Approval For Generic Drug Marketing
  • 12.3.2. Two New Partnerships For The Pharmaceutical Industry
  • 12.3.3. Sun Pharma Completes Acquisition of Concert Pharmaceuticals
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amgen Inc.
• 2. AstraZeneca PLC
• 3. Biogen Inc.
• 4. Boehringer Ingelheim International GmbH
• 5. Bristol Myers Squibb Company
• 6. Eli Lilly & Company
• 7. F. Hoffmann-La Roche AG
• 8. GlaxoSmithKline PLC
• 9. Merck & Co. Inc.
• 10. Novartis AG
• 11. Novo Nordisk A/S
• 12. Pfizer Inc.
• 13. Sanofi S.A.
• 14. Takeda Pharmaceutical Company Limited
• 15. Teva Pharmaceutical Industries Ltd.